Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by...
Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by...
$MLNT is extremely oversold and due for a rally. Huge sort position, MM's trying to drive it lower and found support. Rally is expected at any moment from this area.
Possible Continuation into March 12th earnings. *Expected quarterly revenues up 320%. *Short interest has decreased 50.2% since mid December. *Average daily volume is up 19% over the past 4 days. *NDA filing for Baxdela Phase 3 data 1H 2019 Entry Points: 1.32-1.45 Price Targets: 1.74---2.00---2.26---2.43 Tight Stop-Loss at 1.25 Company Info Melinta...